Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,116 | 63,764 | 116,729 | 85,556 | 82,233 |
| Marketable Securities | 204,689 | 197,921 | 182,776 | 201,986 | 193,697 |
| Receivables | 48,341 | 42,264 | 43,382 | 49,482 | 52,311 |
| Inventories | 10,580 | 10,461 | 10,254 | 8,650 | 8,366 |
| TOTAL | $341,100 | $328,901 | $361,097 | $357,569 | $348,668 |
| Non-Current Assets | |||||
| PPE Net | 104,682 | 100,934 | 97,443 | 84,885 | 74,060 |
| Other Non-Current Assets | 115,395 | 117,970 | 120,016 | 120,332 | 122,001 |
| TOTAL | $220,077 | $218,904 | $217,459 | $205,217 | $196,061 |
| Total Assets | $561,177 | $547,805 | $578,556 | $562,786 | $544,729 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,917 | 1,667 | 417 | 0 | 1,944 |
| Accounts payable and accrued liabilities | 9,668 | 15,038 | 18,711 | 12,211 | 13,181 |
| Accrued Expenses | 26,893 | 19,111 | 38,287 | 31,763 | 24,973 |
| Other current liabilities | 1,500 | 1,000 | 1,000 | 1,000 | 1,000 |
| TOTAL | $56,509 | $48,761 | $68,677 | $55,308 | $50,890 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,158 | 8,399 | 9,640 | 10,049 | 8,096 |
| Other Non-Current Liabilities | 24,894 | 26,616 | 26,717 | 26,802 | 26,877 |
| TOTAL | $34,638 | $37,628 | $39,006 | $40,432 | $38,463 |
| Total Liabilities | $91,147 | $86,389 | $107,683 | $95,740 | $89,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,550 | 30,330 | 29,731 | 29,189 | 29,008 |
| Common Shares | 31 | 30 | 30 | 29 | 29 |
| Retained earnings | -240,866 | -238,806 | -224,284 | -221,952 | -221,451 |
| Other shareholders' equity | -256 | -63 | 267 | 240 | 39 |
| TOTAL | $470,030 | $461,416 | $470,873 | $467,046 | $455,376 |
| Total Liabilities And Equity | $561,177 | $547,805 | $578,556 | $562,786 | $544,729 |